PHOSPHORUS Tablet recall: Labeling Error
PHOSPHORUS Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64980010401
Why was PHOSPHORUS Tablet recalled?
Labeling: Label Mixup; PHOSPHORUS Tablet, 250 mg may be potentially mislabeled as CITALOPRAM, Tablet, 10 mg, NDC 57664050788, Pedigree: AD56921_1, EXP: 5/21/2014; VENLAFAXINE HCL, Tablet, 75 mg, NDC 00093738201, Pedigree: W002533, EXP: 2/28/2014; NITROFURANTOIN MACROCRYSTALS, Capsule, 50 mg, NDC 47781030701, Pedigree: AD25452_4, EXP: 5/3/2014; traZODone HCl, Tablet, 50 mg, NDC 50111043303, P
What should I do if I have this product?
Review the official FDA enforcement record for current instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
PHOSPHORUS Tablet, 250 mg has the following codes Pedigree: AD56916_1, EXP: 5/21/2014; Pedigree: W002534, EXP: 6/3/2014; Pedigree: AD25452_7, EXP: 5/3/2014; Pedigree: AD54498_1, EXP: 5/20/2014; Pedigree: W003997, EXP: 7/1/2014; Pedigree: AD46300_8, EXP: 5/15/2014; Pedigree: AD70639_10, EXP: 5/29/2014.
- Product
- PHOSPHORUS Tablet, 250 mg, Rx only, Distributed by: AidaPak Service, LLC, NDC 64980010401
- Recalling firm
- Aidapak Services, LLC
- Quantity
- 1,000 Tablets
- Distribution
- Repacked drugs were distributed in Arizona, California, Oregon, and Washington.
- Recall date
- January 22, 2014
- Classification
- Class II
- Status
- Terminated
- Agency
- FDA (drug)